In vitro efficacy of Artemisinin-based treatments against SARS-CoV-2
K. Gilmore, Y. Zhou, S. Ramirez, L. V. Pham, U. Fahnoe, S. Feng, A. Offersgaard, J. Trimpert, J. Bukh, K. Osterrieder, J. Gottwein, P. H. Seeberger
This study evaluates the in vitro antiviral efficacy of Artemisia annua extracts and artemisinin derivatives against SARS-CoV-2, finding artesunate to be the most potent.
bioRxiv · Oct 5, 2020 · PreprintPharmacology & Toxicology